Asplenia: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 51: | Line 51: | ||
[[nl:Asplenie]] | [[nl:Asplenie]] | ||
[[fi:Asplenia]] | [[fi:Asplenia]] | ||
[[Category: | |||
[[Category:Medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Primary care]] | |||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} |
Revision as of 02:38, 30 June 2020
Asplenia | |
ICD-10 | D73.0, Q89.0 |
---|---|
ICD-9 | 289.59, 759.01 |
OMIM | 208530 %271400 208540 |
Asplenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Asplenia On the Web |
American Roentgen Ray Society Images of Asplenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Anum Dilip, M.B.B.S[2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Asplenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:Hematology Template:Phakomatoses and other congenital malformations not elsewhere classified